Evolent Health, Inc. 8-K
Research Summary
AI-generated summary
Evolent Health Reports Q1 2026 Quarterly Results (8-K)
What Happened
Evolent Health, Inc. (EVH) announced its financial results for the quarter ended March 31, 2026 and furnished a related press release. The company filed a Current Report on Form 8‑K on May 7, 2026 (Item 2.02) and included the press release as Exhibit 99.1.
Key Details
- Filing date: May 7, 2026; Item reported: 2.02 (Results of Operations and Financial Condition).
- Press release containing the quarterly results is furnished as Exhibit 99.1 to the Form 8‑K.
- The Form 8‑K was signed by Jonathan D. Weinberg, General Counsel and Secretary, on behalf of Evolent Health.
- The filing also includes the cover page formatted as Inline XBRL (Exhibit 104).
Why It Matters
An Item 2.02 8‑K signals the company has publicly released its latest quarterly earnings and related financial information. For investors, this means the new quarterly results, revenue and other operating metrics are now available in the press release (Exhibit 99.1) and should be reviewed to assess Evolent’s recent performance and any impact on guidance or valuation. Because the 8‑K itself furnishes the release rather than including detailed numbers in the filing text, investors should read the attached press release or the company’s investor relations materials for the specific earnings, revenue, and other financial figures.
Loading document...